The Challenge

Business Problem

LifeSignals Inc. needed to perform comprehensive Unit and E2E Testing on their entire software to meet the stringent requirements of the FDA 510(k) submission, ensuring the software's safety, efficacy, and reliability.

The Goal

Achieve FDA 510(k) clearance through rigorous software validation and demonstrate the software's safety, efficacy, and reliability.

Technology Stack

Frontend

Cypress

Backend

JMeterMQTT Explorer

The Solution

Discovery & Architecture

Triophore began by analyzing LifeSignals' software architecture and regulatory requirements to create a detailed testing strategy. The architecture involved multiple components including the ECG patch, mobile app, backend services, and cloud infrastructure. The discovery phase focused on understanding the data flow and interactions between these components to design effective test cases.

Development Phase

Triophore implemented a comprehensive testing regimen that included both Unit and E2E testing. E2E testing simulated real-world user scenarios to validate the entire application flow across all integrated components, ensuring device connectivity, data acquisition, and real-time data display. Unit testing focused on validating individual software components in isolation to ensure each piece of code worked correctly. Detailed reports were generated to document test plans, test cases, execution results, identified bugs, and bug fixes.

Key Feature Implementation

Comprehensive E2E Testing, Rigorous Unit Testing, Detailed Test Reporting Aligned with FDA Guidelines, Validation of Device Connectivity and Data Acquisition, Real-time Data Display Validation

Do you have a project that requires a similar level of technical expertise and strategic thinking?